Editors: A.V. Greco, MD and A. Gasbarrini, MD

Editorial Office Director: Mariella Verduci

Editorial Office Deputy Director: Gianni Lombardi  

European Review for Medical and Pharmacological Sciences

Print ISSN: 1128-3602

Frequency: bimonthly 

Verduci Editore

Via Gregorio VII, 186

00165 Roma

Italia 

Telephone: +39-06.393.75.224

Fax:+39-06.63.85.672 

E-mails:

     Informations: g.lombardi@verduci.it

     Submission: submission@europeanreview.org

     Administration: info@verduci.it 

Website: http://www.europeanreview.org 
 
 

Instructions to the Authors  
 

The European Review for Medical and Pharmacological Sciences, a bi-monthly journal, publishes Editorials, Reviews, Original Papers, and Scientific Correspondence on subjects regarding experimental, laboratory and clinical medicine. 

Editorials and Reviews are normally asked by the Editor, but suitable papers of this type may be submitted for consideration. Appropriate papers are published under the headings Decision Making and Problem Solving and Molecular Basis of Disease. 

Editorials: should be concise. No particular format is required for these articles, which should not include a summary. 

Review: Submission of a paper implies that neither the article nor any essential part of it has been or will be published or submitted for publication elsewhere before appearing in “Eur Rev Med Pharmacol Sci”. Manuscript selection takes place entirely inhouse and has two major objectives: (1) to establish the article’s appropriateness for the journal’s readership; (2) to define the manuscript’s priority ranking relative to other manuscripts under consideration, since the number of papers that the journal receives is greater than which it can publish. Manuscripts that are considered to be either unsuitable for the journal‘s readership or low-priority in comparison with other papers under evaluation will not undergo external in-depth review. Authors of these papers are notified promptly; with in about 2 weeks, that their manuscript cannot be accepted for publication. The remaining articles are reviewed by at least two different external referees. After this peer-evaluation, the final decision on a paper’s acceptability for publication is made by the Editors. 

Reviews provide a comprehensive overview of issues of current interest. No particular format is required but the text should be preceded by an abstract which should be structured as follows: background and objective, evidence and information sources, state of the art, perspectives, conclusions.  

Conflict of Interest Policies: Before final acceptance, authors of research papers or reviews will be asked to sign the following conflict of interest statement: Please provide any pertinent information about the authors’ personal or professional situation that might affect or appear to affect your views on the subject. In particular, disclose any financial support by companies interested in products or processes involved in the work described. A note in the printed paper will indicate that the authors have disclosed a potential conflict of interest. Reviewers are regularly asked to sign the following conflict of interest statement: Please indicate whether you have any relationship (personal or professional situation, in particular any financial interest) that might affect or appear to affect your judgment. Research articles or reviews written by Editorial Board Members are regularly processed by the Editors-in-Chief. 

Time to Publication: Our journal strives to be a forum for rapid exchange of new observations and ideas in Medicine. As such, our objective is to review a paper in 4 weeks and communicate the editorial decision by fax or e-mail within one month of submission. However, it must be noted that Eur Rev Med Pharmacol Sci strongly encourages authors to send their papers via E-mail. We believe that this is a more reliable way of speeding up publication. Papers sent via regular mail or otherwise are excepted to require more time to be processed.

Manuscript

With respect to traditional mail submission, manuscripts, including tables and figures, should be sent via e-mail to facilitate rapid reference. Computer programs employed to prepare the above documents should be listed. 

Title Page: The first page of the manuscript must contain: (a) title, name and surname of the authors; (b) names of the institution(s) where the research was carried out; (c) a running title of no more than 50 letters; (d) aknowledgments; (e) the name and full postal address of the author to whom correspondence regarding the manuscript as well as requests for abstracts should be sent. Phone, fax number and e-mail address of the corresponding author should also be included. 

Abstract: The second page should carry an informative abstract of no more than 250 words which should be intelligible without reference to the text. Original paper abstract should be structured as follows: background and objectives, material and methods, results, and discussion. After the abstract, add three to five key words. 

Material and Methods includes a description of your selection of the observational or experimental subjects. Patients and control subjects should be also described in detail. Name of chemical compounds – not formulas – should be given. The source of any new experimental preparations should be given. This section should be described and referenced in sufficient detail so that other investigators can repeat or extend the study. Describe statistical methods with enough particulars. When necessary, give details about randomization. 

In the Results section the experimental data can be presented in text, tables, or figures, as it seems most appropriate to clarify them. Present the results in logical sequence and use the illustrative material to demontrate the work’s thesis. Specify whether the effects were positive or negative, or there was no effect at all. The results of statistical analysis will be shown there. Report treatment complications and drop-outs if any, detailing both if pertinent to the study. 

Discussion begins focusing on the experimental findings and their interpretation. Avoid repetition of material reviewed in the introduction as well as unnecessary repetition of experimental data. Stress new and important aspects of the work and the conclusions that follow them. Discuss the implications of the data and relate the findings to other relevant studies. Examine any significant difference with previous studies. Avoid statements and conclusions not supported by the results. 

Tables and Ilustrations must be constructed in consideration of the size of the Journal and without repetitions. They should be sent with each table typed on a separate page, progressively numbered with Arabic numerals and accompanied by a caption in English. All illustrations (graphs, drawings, schemes and photographs) must be progressively numbered with Arabic numerals. In place of original drawings, roentgenograms, or other materials, send via mail or e-mail sharp glossy black-and-white photographic prints, ideally 13 by 18 cm and no more than 20 by 25 cm. In preparing illustrations, the final base should be considered the width of a single column, i.e. 8.6 cm (larger illustrations will be accepted only in special cases). Letters and numbers should be large enough to remain legible (> 1 mm) after the figure has been reduced to fit the width of a single column. In preparing composite illustrations, each section should be marked with a small letter in the bottom left corner. Legends for tables and illustrations should be type-written on a separate page. Authors are also encouraged to submit illustrations as electronic files (300 dpi) together with the manuscript text (please, provide what kind of computer and software employed). 

Statistical guidelines. Any statistical method should be detailed in the methods section of the paper and any not in use should be either described in detail or supported by references. Authors are advice to consult: “Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) 1983; 286: 1489-1493”. 

References should be prepared in according to the Vancouver style (for details see: http://www.ama-assn.org/public/peer/wame/uniform.htm or also N Engl J Med 1997; 336: 309-315). References must be numbered consecutively in the order in which they are first cited in the text, and they must be identified in the text by Arabic numerals. Journal abbreviations are those of the List of the Journals Indexed, printed annually in the January issue of the Index Medicus; this list (about 1.3 Mb) can also be obtained on Internet through the US National Library of Medicine website, at the following world-wide-web address: http://www.nlm.nih.gov/tsd/serials/lji.html).

List all authors. 

1) Lebrec D, Poynard T, Hillon P, Benhamou J-P. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. A controlled study. N Engl J Med 1981; 305:1371-1374.

2) Kannan S, Chattopadhyay UK, Pal D. Direct detection of diarrheagenic Aeromonas from faeces by polymerase chain reaction (PCR) targeting aerolysin toxin gene. Eur Rev Med Pharmacol Sci 2001; 5: 91-94.

3) Royal College of Obstetrics and Gynaecologists. Clinical Guideline no 4. The management of infertility in tertiary care. BJU Int 2001; 87: 213-217.

4) The science of climate change. Science 2001; 292: 1261-1272.

5) Tanaka K. Pathology and pathogenesis of Buerger’s disease. Int J Cardiol 1998; 66 (Suppl 1): 237-242. 
 

Books and other monographs (personal authors, chapter in a book, published proceeding paper, abstract book, monograph in a series, agency publication: 

6) Rockwood CA jr, Matsen FA. La Spalla. 2nd ed. Roma: Verduci Editore; 2000.

7) Roizen MF, Fleisher LA. Essenza della pratica anestesiologica. Verduci Editore; 1998.

8) Hill GL. Nutritional assessment and intravenous nutritional support. In: Baker RJ, Fisher JE, eds. Mastery of surgery, II. Philadelphia: Lippincott Williams & Wilkins; 2001.

9) Dreborg S. Proceeding of the 6th annual meeting, European Society of Pediatric Allergy and Immunology. Roma, 1995: Nov 15-18. 

References to Personal Communications and Unpublished data are not accepted. 

Aknowledgements: Brief aknowledgements to specific contributors directly involved in the content of the manuscript may be placed at the end of the text, before the references. Include names of the individuals concerned. Financial support from external institutions, and pharmaceutical companies, for studies on which the manuscript is based, must also be acknowledged. 

Short Reports preferably on methodological topics, and Case reports illustrating salient cases of obvious interest for the clinician, with a brief review of the topic submitted, will be accepted only if they are of particular experience. Case reports should be presented in the usual format of history/introductory comments, brief illustrative presentation, laboratory findings, treatment, and outcome. 

Letters to the Editor pertaining to articles published in the European Review for Medical and Pharmacological Sciences, or to topics of current interest, or referring original findings should not exceed 600 words on length. 

Units of measurements. All clinical chemistry measurements should be reported in the metric system according to the International System of Units (SI) (Ann Intern Med 1987; 106: 114-129). Alternative non-SI units may be given in addition. 

Galley Proofs and Reprints. Galley proofs should be corrected and returned by fax or express delivery within 5 days. Minor corrections or reasonable additions are permitted; however, excessive alterations will be charged to the authors. Papers accepted for publication and reprints may be ordered at cost by returning the appropriate form sent by the publisher. 
 

Papers should be submitted via e-mail to the Editors: 

Prof. A.V. Greco or Prof. A. Gasbarrini

c/o Verduci Publisher

Via Gregorio VII, 186

00165 Roma (Italy)

Phone: +39.06.393.75.224

Fax: +39.06.63.85.672

e-mail: submission@europeanreview.org

Website: www.europeanreview.org